Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Asset Writedowns and Impairment (2021 - 2025)

Health Catalyst filings provide 5 years of Asset Writedowns and Impairment readings, the most recent being $6.9 million for Q3 2025.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A to $6.9 million in Q3 2025 year-over-year; TTM through Dec 2025 was $6.9 million, a N/A change, with the full-year FY2025 number at $6.9 million, changed N/A from a year prior.
  • Asset Writedowns and Impairment hit $6.9 million in Q3 2025 for Health Catalyst, up from -$2.2 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $6.9 million in Q3 2025 to a low of -$2.7 million in Q4 2023.
  • Median Asset Writedowns and Impairment over the past 5 years was $1.2 million (2021), compared with a mean of $1.3 million.
  • Biggest five-year swings in Asset Writedowns and Impairment: surged 640.0% in 2022 and later plummeted 2835.71% in 2023.
  • Health Catalyst's Asset Writedowns and Impairment stood at $500000.0 in 2021, then plummeted by 80.4% to $98000.0 in 2022, then plummeted by 2835.71% to -$2.7 million in 2023, then increased by 17.94% to -$2.2 million in 2024, then soared by 413.64% to $6.9 million in 2025.
  • The last three reported values for Asset Writedowns and Impairment were $6.9 million (Q3 2025), -$2.2 million (Q4 2024), and $2.2 million (Q1 2024) per Business Quant data.